Document:

STOCK
OPTION AGREEMENT, made as of the 23rd day of June, 2017, between BIORESTORATIVE THERAPIES, INC., a Delaware
corporation (the “Company”), and Mark weinreb (the “Optionee”).

 

 

 

WHEREAS,
the Optionee serves as the Chief Executive Officer and Chairman of the Board of the Company;

 

WHEREAS,
the Company desires to provide to the Optionee an additional incentive to promote the success of the Company;

 

WHEREAS,
the Company and the Optionee are parties to an Executive Employment Agreement dated as of March 9, 2015, as amended (the “Employment
Agreement”); and

 

WHEREAS,
capitalized terms used but not defined herein shall have the respective meanings ascribed thereto in the Employment Agreement.

 

NOW,
THEREFORE, in consideration of the foregoing, the Company hereby grants to the Optionee the right and option to purchase
shares of Common Stock of the Company under and pursuant to the terms and conditions of the Company’s 2010 Equity Participation
Plan (the “Plan”) and upon and subject to the following terms and conditions:

 

1.
GRANT OF OPTION. The Company hereby grants to the Optionee the right and option (the “Option”) to purchase
up to Two Hundred Seventy-Five Thousand (275,000) shares of Common Stock of the Company (the “Option Shares”) during
the following periods:

 

(a)
All or any part of Ninety-One Thousand Six Hundred Sixty-Seven (91,667) shares of Common Stock may be purchased during the period
commencing on the date hereof and terminating at 5:00 P.M. on June 23, 2027 (the “Expiration Date”).

 

(b)
All or any part of Ninety-One Thousand Six Hundred Sixty-Seven (91,667) shares of Common Stock may be purchased during the period
commencing at 12:01 A.M. on June 23, 2018 and terminating at 5:00 P.M. on the Expiration Date.

 

(c)
All or any part of Ninety-One Thousand Six Hundred Sixty-Six (91,666) shares of Common Stock may be purchased during the period
commencing at 12:01 A.M. on June 23, 2019 and terminating at 5:00 P.M. on the Expiration Date.

 

Notwithstanding
the foregoing, (i) in the event that the Optionee’s employment with the Company is terminated by the Company Without Cause
or by the Optionee for Good Reason (whether following a Change in Control or otherwise) or (ii) in the event that the Optionee’s
employment with the Company is not terminated by the Company on or prior to the Expiration Date of the Employment Agreement, and
the Optionee does not resign his employment on or prior to the Expiration Date of the Employment Agreement, and, on or prior to
the Expiration Date of the Employment Agreement, the Company and the Optionee, for any reason, do not enter into an agreement
to extend the term of the Employment Agreement (whether on modified terms or otherwise) or enter into a new employment agreement,
and, within three (3) months following the Expiration Date of the Employment Agreement, there is a termination of employment Without
Cause or the Optionee resigns his employment for any reason, and, on the date of termination of employment, any portion of the
Option is not exercisable, such unexercisable portion of the Option shall become exercisable (an “Option Acceleration Event”).

 

    	 	 	 

    	 	 

    

 

2.
NATURE OF OPTION. The Option is not intended to meet the requirements of Section 422 of the Internal Revenue Code
of 1986, as amended, relating to “incentive stock options”.

 

3.
EXERCISE PRICE. The exercise price of each of the Option Shares shall be Three Dollars and Thirty-Five Cents ($3.35)
(the “Exercise Price”). The Company shall pay all original issue or transfer taxes on the exercise of the Option.

 

4.
EXERCISE OF OPTIONS. (a) The Option shall be exercised in accordance with the provisions of the Plan. As soon as
practicable after the receipt of notice of exercise and payment of the Exercise Price as provided for in the Plan, the Company
shall tender to the Optionee a certificate issued in the Optionee’s name evidencing the number of Option Shares covered
thereby.

 

(b)
The Company agrees that, as contemplated in Section 13(b) of the Plan, the Optionee may elect to have the Company reduce the number
of Option Shares otherwise issuable by a number of Option Shares having a Fair Market Value (as defined in the Plan) equal to
the exercise price of the Option being exercised. In the event of such election, the Company shall issue to the Optionee a number
of Option Shares computed using the following formula:

 

	 	X	=	Y
    (A-B)
	 	 	 	    A
	 	 	 	 
	 	Where
    X	=	the
    number of Option Shares to be issued to the Optionee
	 	 	 	 
	 	Y	=	the
    number of Option Shares subject to this Option (or the portion
	 	 	 	thereof
    being cancelled)
	 	 	 	 
	 	A	=	the
    Fair Market Value of one Option Share
	 	 	 	 
	 	B	=	the
    Exercise Price

 

5.
TRANSFERABILITY. The Option shall not be transferable other than by will or the laws of descent and distribution
and, during the Optionee’s lifetime, shall not be exercisable by any person other than the Optionee.

 

6.
TERMINATION OF EMPLOYMENT. To the extent the Option becomes exercisable, the Option shall remain exercisable until
the Expiration Date notwithstanding any subsequent termination of employment with the Company or its subsidiaries for any reason
whatsoever. In addition, in the event of an Option Acceleration Event, the Option shall remain exercisable until the Expiration
Date notwithstanding any termination of employment with the Company or its subsidiaries for any reason whatsoever.

 

7.
INCORPORATION BY REFERENCE. The terms and conditions of the Plan are hereby incorporated by reference and made a
part hereof.

 

    	 	 2	 

    	 	 

    

 

8.
NOTICES. Any notice or other communication given hereunder shall be deemed sufficient if in writing and hand delivered
or sent by registered or certified mail, return receipt requested, addressed to the Company, 40 Marcus Drive, Suite One, Melville,
New York 11747, Attention: Vice President of Operations, and to the Optionee at the address indicated below. Notices shall be
deemed to have been given on the date of hand delivery or mailing, except notices of change of address, which shall be deemed
to have been given when received.

 

9.
BINDING EFFECT. This Stock Option Agreement shall be binding upon and inure to the benefit of the parties hereto
and their respective legal representatives, successors and assigns.

 

10.
ENTIRE AGREEMENT. This Stock Option Agreement, together with the Plan, contains the entire understanding of the
parties hereto with respect to the subject matter hereof and may be modified only by an instrument executed by the party sought
to be charged.

 

11.
GOVERNING LAW. This Stock Option Agreement shall be governed by, and construed in accordance with, the laws of the
State of Delaware, excluding choice of law rules thereof.

 

12.
EXECUTION IN COUNTERPARTS. This Stock Option Agreement may be executed in counterparts, each of which shall be deemed
to be an original, but both of which together shall constitute one and the same instrument.

 

13.
FACSIMILE SIGNATURES. Signatures hereon which are transmitted via facsimile, or other electronic image, shall be
deemed original signatures.

 

14.
INTERPRETATION; HEADINGS. The provisions of this Stock Option Agreement shall be interpreted in a reasonable manner
to give effect to the intent of the parties hereto. The headings and captions under sections and paragraphs of this Stock Option
Agreement are for convenience of reference only and do not in any way modify, interpret or construe the intent of the parties
or affect any of the provisions of this Stock Option Agreement.

 

[Signature
page follows]

 

    	 	 3	 

    	 	 

    

 

 

IN
WITNESS WHEREOF, the parties have executed this Stock Option Agreement as of the day and year first above written.

 

	 	BIORESTORATIVE
    THERAPIES, INC.
	 	 	 
	 	By:	/s/
    Mandy Clyde
	 	 	Name:
    Mandy Clyde
	 	 	Title:
    Vice President of Operations
	 	 	 
	 	 	/s/
    Mark Weinreb
	 	 	Signature
    of Optionee
	 	 	 
	 	 	Mark
    Weinreb
	 	 	Name
    of Optionee
	 	 	 
	 	 	40
    Marcus Drive
	 	 	Melville,
    NY 11747
	 	 	Address
    of Optionee

 

    	 	 4STOCK
OPTION AGREEMENT, made as of the 23rd day of June, 2017, between BIORESTORATIVE THERAPIES, INC., a Delaware
corporation (the “Company”), and _______________________ (the “Optionee”).

 

 

 

WHEREAS,
the Optionee serves as a director of the Company; and

 

WHEREAS,
the Company desires to provide to the Optionee an additional incentive to promote the success of the Company.

 

NOW,
THEREFORE, in consideration of the foregoing, the Company hereby grants to the Optionee the right and option to purchase
shares of Common Stock of the Company under and pursuant to the terms and conditions of the Company’s 2010 Equity Participation
Plan (the “Plan”) and upon and subject to the following terms and conditions:

 

1.
GRANT OF OPTION. The Company hereby grants to the Optionee the right and option (the “Option”) to purchase
up to __________________________ (______) shares of Common Stock of the Company (the “Option Shares”) during the following
periods:

 

(a)
All or any part of __________________________ (______) shares of Common Stock may be purchased during the period commencing on
the date hereof and terminating at 5:00 P.M. on June 23, 2027 (the “Expiration Date”).

 

(b)
All or any part of __________________________ (______) shares of Common Stock may be purchased during the period commencing at
12:01 A.M. on June 23, 2018 and terminating at 5:00 P.M. on the Expiration Date.

 

(c)
All or any part of __________________________ (______) shares of Common Stock may be purchased during the period commencing at
12:01 A.M. on June 23, 2019 and terminating at 5:00 P.M. on the Expiration Date.

 

2.
NATURE OF OPTION. The Option is not intended to meet the requirements of Section 422 of the Internal Revenue Code
of 1986, as amended, relating to “incentive stock options”.

 

3.
EXERCISE PRICE. The exercise price of each of the Option Shares shall be Three Dollars and Thirty-Five Cents ($3.35)
(the “Exercise Price”). The Company shall pay all original issue or transfer taxes on the exercise of the Option.

 

4.
EXERCISE OF OPTIONS. (a) The Option shall be exercised in accordance with the provisions of the Plan. As soon as
practicable after the receipt of notice of exercise and payment of the Exercise Price as provided for in the Plan, the Company
shall tender to the Optionee a certificate issued in the Optionee’s name evidencing the number of Option Shares covered
thereby.

 

    	 

    	 

    

 

(b)
The Company agrees that, as contemplated in Section 13(b) of the Plan, the Optionee may elect to have the Company reduce the number
of Option Shares otherwise issuable by a number of Option Shares having a Fair Market Value (as defined in the Plan) equal to
the exercise price of the Option being exercised. In the event of such election, the Company shall issue to the Optionee a number
of Option Shares computed using the following formula:

 

	X	=	Y
    (A-B)
	 	 	A
	 	 	 
	Where
    X	=	the
    number of Option Shares to be issued to the Optionee
	 	 	 
	Y	=	the
    number of Option Shares subject to this Option (or the portion thereof being cancelled)
	 	 	 
	A	=	the
    Fair Market Value of one Option Share
	 	 	 
	B	=	the
    Exercise Price

 

5.
TRANSFERABILITY. The Option shall not be transferable other than by will or the laws of descent and distribution
and, during the Optionee’s lifetime, shall not be exercisable by any person other than the Optionee.

 

6.
TERMINATION OF DIRECTORSHIP. To the extent the Option becomes exercisable, the Option shall remain exercisable until
twelve (12) months following any subsequent termination of directorship with the Company or its subsidiaries for any reason whatsoever
but in no event shall the Option be exercisable after the Expiration Date.

 

7.
INCORPORATION BY REFERENCE. The terms and conditions of the Plan are hereby incorporated by reference and made a
part hereof.

 

8.
NOTICES. Any notice or other communication given hereunder shall be deemed sufficient if in writing and hand delivered
or sent by registered or certified mail, return receipt requested, addressed to the Company, 40 Marcus Drive, Suite One, Melville,
New York 11747, Attention: Chief Executive Officer, and to the Optionee at the address indicated below. Notices shall be deemed
to have been given on the date of hand delivery or mailing, except notices of change of address, which shall be deemed to have
been given when received.

 

9.
BINDING EFFECT. This Stock Option Agreement shall be binding upon and inure to the benefit of the parties hereto
and their respective legal representatives, successors and assigns.

 

10.
ENTIRE AGREEMENT. This Stock Option Agreement, together with the Plan, contains the entire understanding of the
parties hereto with respect to the subject matter hereof and may be modified only by an instrument executed by the party sought
to be charged.

 

    	2 

    	 

    

 

11.
GOVERNING LAW. This Stock Option Agreement shall be governed by, and construed in accordance with, the laws of the
State of Delaware, excluding choice of law rules thereof.

 

12.
EXECUTION IN COUNTERPARTS. This Stock Option Agreement may be executed in counterparts, each of which shall be deemed
to be an original, but both of which together shall constitute one and the same instrument.

 

13.
FACSIMILE SIGNATURES. Signatures hereon which are transmitted via facsimile, or other electronic image, shall be
deemed original signatures.

 

14.
INTERPRETATION; HEADINGS. The provisions of this Stock Option Agreement shall be interpreted in a reasonable manner
to give effect to the intent of the parties hereto. The headings and captions under sections and paragraphs of this Stock Option
Agreement are for convenience of reference only and do not in any way modify, interpret or construe the intent of the parties
or affect any of the provisions of this Stock Option Agreement.

 

[Remainder
of page intentionally left blank; signature page follows]

 

    	3 

    	 

    

 

IN
WITNESS WHEREOF, the parties have executed this Stock Option Agreement as of the day and year first above written.

 

	 	BIORESTORATIVE THERAPIES, INC.
	 	 	 
	 	By:	 
	 	Name:	Mark
    Weinreb
	 	Title:	Chief
    Executive Officer

 

	 	 
	 	Signature
    of Optionee
	 	 
	 	 
	 	Name
    of Optionee
	 	 
	 	 
	 	Address
    of Optionee

 

    	4

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00275-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00275-of-00352.parquet"}]]